Tibulizumab (Anti-BAFF & IL-17)

製品コード:A4001        

印刷

Tibulizumab (LY3090106) is a tetravalent bispecific antibody which potently inhibits both B cell activating factor (BAFF), also known as CD257 and interleukin-17A (IL-17). It is used for the treatment of autoimmune diseases. MW: 201.44 KD.

製品説明

CAS No. 1849636-24-3
Isotype IgG4-kappa
Source CHO
Storage
(From the date of receipt)
-80℃(avoid freeze-thaw cycles)
Shipping Shipped under low temperature conditions

人間や獣医の診断であるか治療的な使用のためにでない。